|
|
|
Total Number of Holdings (excluding cash): 85
Natera, Inc. |
NTRA |
632307104 |
Medical Equipment and Services |
395,005 |
$35,597,850.60 |
2.73% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Pharmaceuticals and Biotechnology |
80,721 |
$31,555,453.32 |
2.42% |
The Cigna Group |
CI |
125523100 |
Health Care Providers |
82,629 |
$29,137,464.27 |
2.23% |
Universal Health Services, Inc. (Class B) |
UHS |
913903100 |
Health Care Providers |
162,314 |
$28,778,272.20 |
2.20% |
Molina Healthcare, Inc. |
MOH |
60855R100 |
Health Care Providers |
68,481 |
$28,101,178.35 |
2.15% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals and Biotechnology |
245,468 |
$27,040,754.88 |
2.07% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals and Biotechnology |
2,284,687 |
$26,867,919.12 |
2.06% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals and Biotechnology |
112,525 |
$26,327,474.25 |
2.02% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Pharmaceuticals and Biotechnology |
187,789 |
$26,185,298.16 |
2.00% |
DaVita Inc. |
DVA |
23918K108 |
Health Care Providers |
188,950 |
$25,889,929.00 |
1.98% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals and Biotechnology |
33,957 |
$25,897,645.62 |
1.98% |
Centene Corporation |
CNC |
15135B101 |
Health Care Providers |
333,421 |
$25,680,085.42 |
1.97% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals and Biotechnology |
482,230 |
$24,878,245.70 |
1.90% |
Premier, Inc. (Class A) |
PINC |
74051N102 |
Health Care Providers |
1,106,581 |
$24,112,399.99 |
1.85% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Pharmaceuticals and Biotechnology |
1,031,396 |
$23,897,445.32 |
1.83% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals and Biotechnology |
859,436 |
$23,823,565.92 |
1.82% |
ICON Plc |
ICLR |
G4705A100 |
Medical Equipment and Services |
69,928 |
$23,251,759.28 |
1.78% |
Quest Diagnostics Incorporated |
DGX |
74834L100 |
Medical Equipment and Services |
179,455 |
$22,995,363.70 |
1.76% |
Encompass Health Corporation |
EHC |
29261A100 |
Health Care Providers |
296,680 |
$22,544,713.20 |
1.73% |
Envista Holdings Corporation |
NVST |
29415F104 |
Medical Equipment and Services |
1,028,394 |
$22,038,483.42 |
1.69% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Pharmaceuticals and Biotechnology |
83,732 |
$21,948,669.16 |
1.68% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Pharmaceuticals and Biotechnology |
22,537 |
$21,633,717.04 |
1.66% |
Elevance Health Inc. |
ELV |
036752103 |
Health Care Providers |
41,976 |
$21,462,328.80 |
1.64% |
Karuna Therapeutics, Inc. |
KRTX |
48576A100 |
Pharmaceuticals and Biotechnology |
62,541 |
$20,627,898.03 |
1.58% |
Medtronic Plc |
MDT |
G5960L103 |
Medical Equipment and Services |
240,283 |
$20,102,075.78 |
1.54% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals and Biotechnology |
48,649 |
$20,013,225.62 |
1.53% |
ICU Medical, Inc. |
ICUI |
44930G107 |
Medical Equipment and Services |
198,461 |
$19,681,377.37 |
1.51% |
Tenet Healthcare Corporation |
THC |
88033G407 |
Health Care Providers |
196,453 |
$19,719,952.14 |
1.51% |
Henry Schein, Inc. |
HSIC |
806407102 |
Medical Equipment and Services |
261,452 |
$19,394,509.36 |
1.48% |
IDEXX Laboratories, Inc. |
IDXX |
45168D104 |
Medical Equipment and Services |
35,662 |
$18,894,084.22 |
1.45% |
Bruker Corporation |
BRKR |
116794108 |
Medical Equipment and Services |
202,041 |
$18,591,812.82 |
1.42% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals and Biotechnology |
615,120 |
$18,459,751.20 |
1.41% |
Maravai LifeSciences Holdings, Inc. (Class A) |
MRVI |
56600D107 |
Pharmaceuticals and Biotechnology |
2,266,550 |
$18,041,738.00 |
1.38% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals and Biotechnology |
244,346 |
$17,900,787.96 |
1.37% |
HCA Healthcare, Inc. |
HCA |
40412C101 |
Health Care Providers |
54,846 |
$17,943,965.82 |
1.37% |
Danaher Corporation |
DHR |
235851102 |
Medical Equipment and Services |
64,174 |
$16,137,835.78 |
1.24% |
10X Genomics, Inc. (Class A) |
TXG |
88025U109 |
Pharmaceuticals and Biotechnology |
442,157 |
$15,953,024.56 |
1.22% |
Humana Inc. |
HUM |
444859102 |
Health Care Providers |
43,237 |
$15,011,454.03 |
1.15% |
QIAGEN N.V. |
QGEN |
N72482149 |
Medical Equipment and Services |
341,563 |
$15,076,590.83 |
1.15% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals and Biotechnology |
120,698 |
$14,895,340.18 |
1.14% |
Ultragenyx Pharmaceutical Inc. |
RARE |
90400D108 |
Pharmaceuticals and Biotechnology |
310,453 |
$14,464,005.27 |
1.11% |
Globus Medical, Inc. (Class A) |
GMED |
379577208 |
Medical Equipment and Services |
278,588 |
$14,389,070.20 |
1.10% |
Apellis Pharmaceuticals, Inc. |
APLS |
03753U106 |
Pharmaceuticals and Biotechnology |
248,010 |
$13,953,042.60 |
1.07% |
Laboratory Corporation of America Holdings |
LH |
50540R409 |
Medical Equipment and Services |
65,317 |
$13,686,524.18 |
1.05% |
UnitedHealth Group Incorporated |
UNH |
91324P102 |
Health Care Providers |
28,199 |
$13,734,322.95 |
1.05% |
QuidelOrtho Corporation |
QDEL |
219798105 |
Medical Equipment and Services |
268,583 |
$13,160,567.00 |
1.01% |
Roivant Sciences Ltd. |
ROIV |
G76279101 |
Pharmaceuticals and Biotechnology |
1,321,986 |
$13,048,001.82 |
1.00% |
Teleflex Incorporated |
TFX |
879369106 |
Medical Equipment and Services |
59,541 |
$12,888,840.27 |
0.99% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals and Biotechnology |
75,218 |
$12,838,960.42 |
0.98% |
Biogen Inc. |
BIIB |
09062X103 |
Pharmaceuticals and Biotechnology |
57,371 |
$12,587,197.40 |
0.96% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals and Biotechnology |
686,356 |
$12,224,000.36 |
0.94% |
GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
Medical Equipment and Services |
128,004 |
$11,598,442.44 |
0.89% |
Integra LifeSciences Holdings Corporation |
IART |
457985208 |
Medical Equipment and Services |
340,893 |
$11,672,176.32 |
0.89% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
Medical Equipment and Services |
29,337 |
$11,518,292.94 |
0.88% |
Chemed Corporation |
CHE |
16359R103 |
Health Care Providers |
16,925 |
$10,985,002.00 |
0.84% |
IQVIA Holdings Inc. |
IQV |
46266C105 |
Health Care Providers |
42,775 |
$10,859,289.25 |
0.83% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
Medical Equipment and Services |
18,646 |
$10,815,612.30 |
0.83% |
DexCom, Inc. |
DXCM |
252131107 |
Medical Equipment and Services |
79,759 |
$10,745,132.48 |
0.82% |
Hologic, Inc. |
HOLX |
436440101 |
Medical Equipment and Services |
138,520 |
$10,576,002.00 |
0.81% |
Tandem Diabetes Care, Inc. |
TNDM |
875372203 |
Medical Equipment and Services |
334,593 |
$10,412,534.16 |
0.80% |
Steris Plc |
STE |
G8473T100 |
Medical Equipment and Services |
45,019 |
$10,354,370.00 |
0.79% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
Medical Equipment and Services |
81,325 |
$10,243,697.00 |
0.78% |
Abbott Laboratories |
ABT |
002824100 |
Medical Equipment and Services |
89,918 |
$10,110,379.92 |
0.77% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals and Biotechnology |
63,144 |
$9,898,453.44 |
0.76% |
Revvity, Inc. |
RVTY |
714046109 |
Medical Equipment and Services |
90,542 |
$9,430,854.72 |
0.72% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals and Biotechnology |
34,364 |
$9,309,207.60 |
0.71% |
Incyte Corporation |
INCY |
45337C102 |
Pharmaceuticals and Biotechnology |
157,624 |
$9,038,160.16 |
0.69% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Pharmaceuticals and Biotechnology |
133,782 |
$7,874,408.52 |
0.60% |
R1 RCM Inc. |
RCM |
77634L105 |
Health Care Providers |
468,176 |
$6,165,877.92 |
0.47% |
Stryker Corporation |
SYK |
863667101 |
Medical Equipment and Services |
16,525 |
$5,851,172.00 |
0.45% |
Masimo Corporation |
MASI |
574795100 |
Medical Equipment and Services |
42,220 |
$5,633,836.80 |
0.43% |
Avantor, Inc. |
AVTR |
05352A100 |
Medical Equipment and Services |
216,760 |
$5,520,877.20 |
0.42% |
Baxter International Inc. |
BAX |
071813109 |
Medical Equipment and Services |
128,004 |
$5,317,286.16 |
0.41% |
Repligen Corporation |
RGEN |
759916109 |
Medical Equipment and Services |
27,524 |
$5,346,537.00 |
0.41% |
Agilent Technologies, Inc. |
A |
00846U101 |
Medical Equipment and Services |
35,595 |
$5,200,073.55 |
0.40% |
Enovis Corp. |
ENOV |
194014502 |
Medical Equipment and Services |
88,336 |
$5,188,856.64 |
0.40% |
The Cooper Companies, Inc. |
COO |
216648501 |
Medical Equipment and Services |
52,305 |
$5,273,390.10 |
0.40% |
Certara, Inc. |
CERT |
15687V109 |
Medical Equipment and Services |
281,331 |
$5,139,917.37 |
0.39% |
Doximity, Inc. (Class A) |
DOCS |
26622P107 |
Health Care Providers |
176,485 |
$4,920,401.80 |
0.38% |
Becton, Dickinson and Company |
BDX |
075887109 |
Medical Equipment and Services |
20,294 |
$4,824,289.68 |
0.37% |
Bio-Techne Corporation |
TECH |
09073M104 |
Medical Equipment and Services |
64,134 |
$4,609,951.92 |
0.35% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals and Biotechnology |
51,324 |
$4,301,464.44 |
0.33% |
Sotera Health Company |
SHC |
83601L102 |
Medical Equipment and Services |
293,687 |
$4,208,534.71 |
0.32% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals and Biotechnology |
97,817 |
$4,111,248.51 |
0.31% |
Insulet Corporation |
PODD |
45784P101 |
Medical Equipment and Services |
22,807 |
$3,915,505.76 |
0.30% |
US Dollar |
$USD |
|
Other |
2,256,758 |
$2,256,757.87 |
0.17% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|